Does taking an over-the-counter oral DHEA supplement actually help with menopause symptoms like hot flashes, mood, or energy?

DHEA (dehydroepiandrosterone) is a hormone made mainly by the adrenal glands that serves as a raw material tissues throughout the body convert, locally, into small amounts of estrogen and testosterone.

Levels decline steadily with age, which is part of why oral DHEA is marketed as a way to restore youthful hormone levels and relieve menopause symptoms. The trouble is that when this idea has actually been tested, the results are underwhelming for the symptoms most women ask about. The best available evidence, a 2015 Cochrane systematic review pooling 28 randomized trials in 1,273 peri- and postmenopausal women, found no improvement in overall quality of life with DHEA compared with placebo, and it was unclear whether DHEA eases classic symptoms like hot flashes because trials measured them too inconsistently to combine. The single largest trial testing oral DHEA on its own, 50 mg daily for a full year in 93 women, found no benefit for psychological well-being or menopause-specific quality of life over placebo either. There was a modest signal for improved sexual function pooled across all DHEA trials, but that appears driven mainly by studies of vaginal, not oral, DHEA. Oral DHEA also carried a real cost: women taking it were significantly more likely to develop androgenic side effects like acne. Because it is sold as a dietary supplement rather than a regulated drug, the dose and purity in any given bottle also aren't independently verified the way a prescription medication's would be. In short, current evidence doesn't support oral DHEA for hot flashes, mood, or energy, and it isn't something to start without medical guidance.

What to know about this answer

Population-level trial evidence, especially the 2015 Cochrane review, finds no clear benefit of oral DHEA for menopausal quality of life and a real signal for androgenic side effects, which is why most evidence-based guidance doesn't recommend it for hot flashes, mood, or energy. But a smaller strand of research, associated with the intracrinology framework that also produced FDA-approved vaginal DHEA, has reported benefits, particularly for sexual function, in individual trials using different doses or comparator groups, and argues that population averages may hide a real effect in the subset of women with genuinely low DHEA levels.

What the research shows, and which source each finding rests on

DHEA (dehydroepiandrosterone) is a steroid hormone produced mainly by the adrenal cortex that has weak hormonal activity on its own, but that peripheral tissues convert locally into androgens and estrogens, a process called intracrinology; circulating DHEA falls by roughly 60% between a woman's early thirties and the age of menopause.

?[4]

A 2015 Cochrane systematic review and meta-analysis of 28 randomized controlled trials in 1,273 peri- and postmenopausal women found no improvement in quality of life with DHEA versus placebo (standardized mean difference 0.16, 95% CI -0.03 to 0.34), could not determine a clear effect on core menopausal symptoms like hot flashes because trials measured them too inconsistently to pool, and found DHEA was associated with significantly higher odds of androgenic side effects, mainly acne (odds ratio 3.77, 95% CI 1.36 to 10.4).

?[1]

The largest randomized trial of oral-only DHEA (50 mg daily for 52 weeks in 93 postmenopausal women with low libido, not using estrogen therapy) found no significant difference from placebo in psychological well-being (Psychological General Well-Being Questionnaire) or menopause-specific quality of life (MENQOL), and androgenic side effects such as acne and increased hair growth were more common in the DHEA group.

?[2]

In that same 52-week trial cohort, 50 mg daily oral DHEA did not significantly alter blood lipid profile or insulin sensitivity, and did not produce concerning endometrial changes on ultrasound, though the sample size and duration are still too limited to rule out rarer or longer-term risks.

?[3]

Where the real disagreement is

Each position is shown with its own sources. A position listed here is not necessarily the accepted view.

The population-level evidence doesn't support it

Cochrane systematic reviewers and most evidence-based menopause guidance

The 2015 Cochrane meta-analysis of 28 randomized trials found no quality-of-life benefit from DHEA over placebo, an inconsistent effect on menopausal symptoms, and a significantly higher risk of androgenic side effects; the single largest randomized trial of oral-only DHEA confirmed no benefit on well-being or menopause-specific quality of life over placebo.

?[1]?[2]

Individual trials and the intracrinology framework suggest a real, if narrow, benefit

Researchers in the DHEA and intracrinology research tradition, and clinicians who report sexual-function improvement in practice

A 12-month, non-blinded trial of oral DHEA 10 mg daily found significant improvement in sexual function scores from baseline, while a comparison group of women who had declined hormonal therapy (given vitamin D instead) showed no such change. The Cochrane review's own pooled analysis also found a modest but statistically significant improvement in sexual function across all DHEA trials combined. Proponents argue that averaging results across women with normal versus genuinely low DHEA levels, and across different doses and durations, may mask a real effect in the subset of women most likely to respond.

?[5]?[1]

What would settle it: An adequately powered, placebo-controlled trial of oral DHEA alone (not pooled with vaginal-route data), with hot flashes, validated mood and energy measures, and sexual function all defined as pre-specified primary outcomes, and results stratified by baseline DHEA-S level to test whether women who start out lowest respond differently.

What is really going on here

Does the modest sexual-function signal in the Cochrane meta-analysis actually apply to oral supplements, or is it being driven mainly by the vaginal-route trials pooled into the same analysis?
If a trial finds a significant improvement on a well-being questionnaire but the same trial group's hot flashes or quality-of-life scores don't move, does that count as the supplement working for the reasons it's marketed for?
Since over-the-counter DHEA isn't held to the same manufacturing and dose-accuracy standards as a regulated drug, does the dose actually being taken match the milligrams printed on the label?

Questions for your doctor

Given my actual DHEA-S blood level and health history, is there any reason to think I'd respond differently to DHEA than the average woman in these trials?
Are there specific health conditions of mine that would make DHEA riskier, like a history of hormone-sensitive cancer, PCOS, or acne?
If I'm mainly bothered by hot flashes, mood, or energy specifically, is there a treatment with clearer evidence, like hormone therapy or a non-hormonal option, that we should discuss first?
How would we monitor for side effects like acne, hair growth, or lipid changes if I did try it?

Questions with no answer yet

Does oral DHEA specifically, separate from the vaginal-route data pooled into the same meta-analysis, meaningfully improve sexual function on its own?

Mixed

What is known: In the Cochrane review's subgroup analysis, oral-only DHEA trials showed a small improvement in sexual function that did not reach statistical significance (standardized mean difference 0.11, 95% CI -0.13 to 0.35), while a single large trial of vaginal DHEA showed a significant benefit, though the difference between the oral and vaginal subgroups was not itself statistically significant.

What would test it: A larger, adequately powered, placebo-controlled trial of oral DHEA alone, with validated sexual function measures as a pre-specified primary outcome.

Do specific subgroups, such as women with confirmed adrenal insufficiency or genuinely low baseline DHEA-S, benefit more from oral DHEA than the average postmenopausal woman studied so far?

Not directly studied yet

No research does not mean it does not work, and it does not mean it works. It means nobody has tested it yet.

What is known: Review literature notes that trials in women with confirmed adrenal insufficiency have shown more consistent mood and libido improvement than trials in generally healthy postmenopausal women, but those studies have short follow-up periods and small sample sizes, and no adequately powered trial has stratified a general menopausal population by baseline DHEA-S level to test for a differential response.

What would test it: An adequately powered randomized trial that enrolls postmenopausal women across a range of baseline DHEA-S levels and pre-specifies baseline level as a stratification variable for symptom and quality-of-life outcomes.

Sources

The letter grades the type of study behind a claim, not the answer itself.

This page is general information based on published research and public sources. It is not medical advice and not a personal assessment, and it does not replace a conversation with your doctor. Peritale is a wellness product, not a medical device, and is not intended to diagnose, treat, cure or prevent any disease. For any medical question, speak with a licensed clinician.

You are not imagining it

In about seven minutes on your phone, Peritale reads five signal systems and maps your symptoms, so you can see that what you feel is real, follow your hormonal transition over time, and walk into your doctor ready to ask for the care you deserve. Your first check is free, no credit card.

Start Free Mapping